Drug Discovery Technology Alert. Recombinantly Produced Biomimetic Vesicles for Targeted Drug Delivery; Stem Cell-Based Technology for Delivery of Cell-Based Therapies; Chemistry-Based Drug Repurposing Approach Offers Distinct Advantages
This issue profiles recombinantly produced biomimetic vesicles for targeted drug delivery, stem cell-based technology for delivery of cell-based therapies, and a chemistry-based drug repurposing approach offers distinct advantages.
Click headings to expand and collapse
Published: 13 Jul 2012
Tools
Features of this research
Help Desk
For more information and general enquiries, contact Frost & Sullivan near you.
Select a location near you..